Article ID Journal Published Year Pages File Type
10969273 Vaccine 2012 9 Pages PDF
Abstract
► Consistency of 3 lots of Hexaxim was demonstrated. ► Good immunogenicity following Hexaxim 2, 4, 6 month primary series, similar to control. ► High degree of antibody persistence at 15-18 months of age. ► Strong immune response following Hexaxim booster. ► No safety concerns for primary series or booster vaccinations.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , ,